Allotera Therapeutics, Inc. — Form D

Allotera Therapeutics, Inc. of ST. LOUIS, MO, a company, filed a Form D exempt-offering notice with the SEC on 2021-07-23. The offering totals $172.0M, of which $98.5M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (35)

Showing 25 of 35 people.

NameRoleLocation
Drew P DennisonDirectorSt. Louis, MO
Bosun P HauDirectorSt. Louis, MO
Daniel M KempDirectorSt. Louis, MO
Peter P KienerDirectorSt. Louis, MO
Kevin P LiDirectorSt. Louis, MO
John P McKearnDirectorSt. Louis, MO
Bali K MuralidharDirectorSt. Louis, MO
Matthew P CooperExecutive OfficerSt. Louis, MO
Jan K DavidsonExecutive OfficerSt. Louis, MO
Ayman P KabakibiExecutive OfficerSt. Louis, MO
Daniel M KempExecutive OfficerSt. Louis, MO
Matthew CooperExecutive OfficerAnn Arbor, MI
Matthew CooperRelated PersonAnn Arbor, MI
Bali MuralidharDirectorSt. Louis, MO
Bali MuralidharRelated PersonSt. Louis, MO
Natalie MountDirectorSt. Louis, MO
Natalie MountRelated PersonSt. Louis, MO
Ayman KabakibiExecutive OfficerSt. Louis, MO
Ayman KabakibiRelated PersonSt. Louis, MO
Drew DennisonDirectorSt. Louis, MO
Drew DennisonRelated PersonSt. Louis, MO
Niall O'DonnellDirectorSt. Louis, MO
Niall O'DonnellRelated PersonSt. Louis, MO
Bosun HauDirectorSt. Louis, MO
Bosun HauRelated PersonSt. Louis, MO

Other filings by this issuer (3)

FiledFormOfferingSold
2026-07-23D/A$163.0M$123.3M
2025-09-08D$163.0M$109.5M
2021-07-23D$37.2M$37.2M

More